366 related articles for article (PubMed ID: 8179341)
1. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.
Friedmann PS; Strickland I; Pirmohamed M; Park BK
Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341
[TBL] [Abstract][Full Text] [Related]
2. T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells.
Miyauchi H; Hosokawa H; Akaeda T; Iba H; Asada Y
Arch Dermatol; 1991 Jun; 127(6):851-5. PubMed ID: 2036032
[TBL] [Abstract][Full Text] [Related]
3. Impaired antigen presentation in toxic epidermal necrolysis.
Bagot M; Charue D; Heslan M; Wechsler J; Roujeau JC; Revuz J
Arch Dermatol; 1993 Jun; 129(6):721-7. PubMed ID: 8507074
[TBL] [Abstract][Full Text] [Related]
4. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing between erythema multiforme major and Stevens-Johnson syndrome/toxic epidermal necrolysis immunopathologically.
Iwai S; Sueki H; Watanabe H; Sasaki Y; Suzuki T; Iijima M
J Dermatol; 2012 Sep; 39(9):781-6. PubMed ID: 22458564
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case.
Merot Y; Gravallese E; Guillén FJ; Murphy GF
Arch Dermatol; 1986 Apr; 122(4):455-8. PubMed ID: 2937370
[TBL] [Abstract][Full Text] [Related]
7. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
Mizukawa Y; Yamazaki Y; Shiohara T
Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767
[TBL] [Abstract][Full Text] [Related]
8. Mucocutaneous eruptions due to antiepileptic drug therapy in children.
Pollack MA; Burk PG; Nathanson G
Ann Neurol; 1979 Mar; 5(3):262-7. PubMed ID: 443758
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement.
Correia O; Delgado L; Ramos JP; Resende C; Torrinha JA
Arch Dermatol; 1993 Apr; 129(4):466-8. PubMed ID: 8466217
[TBL] [Abstract][Full Text] [Related]
10. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.
Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E
Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350
[TBL] [Abstract][Full Text] [Related]
11. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI
Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
[TBL] [Abstract][Full Text] [Related]
12. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
13. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
[No Abstract] [Full Text] [Related]
14. Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine.
Goh TK; Pang SM; Thirumoorthy T; Goh SG
Singapore Med J; 2008 Jun; 49(6):507-10. PubMed ID: 18581028
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced toxic epidermal necrolysis and pancytopenia: a puzzling association.
Paquet P; Jacob E; Pirson J; Pierard GE
Int J Mol Med; 2005 Jul; 16(1):29-33. PubMed ID: 15942674
[TBL] [Abstract][Full Text] [Related]
17. Two cases of pustular toxic epidermal necrolysis.
Hague JS; Kaur MR; Hafiji J; Carr RA; Lewis H; Charles-Holmes R; Heagerty A; Orpin SD
Clin Exp Dermatol; 2011 Jan; 36(1):42-5. PubMed ID: 20497187
[TBL] [Abstract][Full Text] [Related]
18. Vesicular Contact Reaction May Progress into Erythema Multiforme.
Czarnecka-Operacz M; Jenerowicz D; Szulczyńska-Gabor J; Teresiak-Mikołajczak E; Szyfter-Harris J; Bowszyc-Dmochowska M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):307-309. PubMed ID: 28128086
[TBL] [Abstract][Full Text] [Related]
19. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.
Nassif A; Bensussan A; Boumsell L; Deniaud A; Moslehi H; Wolkenstein P; Bagot M; Roujeau JC
J Allergy Clin Immunol; 2004 Nov; 114(5):1209-15. PubMed ID: 15536433
[TBL] [Abstract][Full Text] [Related]
20. Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.
Paquet P; Jacob E; Damas P; Pirson J; Piérard G
Arch Dermatol Res; 2005 Dec; 297(6):266-73. PubMed ID: 16249890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
